Where complexity creates value.
Products that are hard to make, register or launch, built with global partners.
Areas of focus
Products needing specialized development, manufacturing or regulatory strategy.
Improved formulations, delivery characteristics or market positioning for existing molecules.
Peptides and other high-value specialized molecules from global partners.
New dosage forms and formulation technologies with commercial potential.
First-to-market and first-generic
Selected opportunities, each assessed for intellectual property, exclusivities, technical feasibility and commercial potential.
How a product joins our portfolio
Identify
Screen product and technology opportunities.
Evaluate
Assess feasibility, regulation, IP and market potential.
Partner
Engage technology owners and manufacturers.
Advance
Coordinate licensing, transfer and registration.
Commercialize
Build the market-entry and supply plan.
Availability, status, timing and market rights depend on individual agreements.